Results 191 to 200 of about 20,482 (221)
Some of the next articles are maybe not open access.
Polyneuropathy and benign monoclonal gammopathy
Clinical Neurology and Neurosurgery, 1983Recently the rather frequent occurrence of benign monoclonal gammopathy (BMG) has been reported in peripheral neuropathy. Sometimes this syndrome is part of a multisystemic disorder in which organomegaly, endocrine disturbances, skin changes and focal bone lesions may also occur.
HOOGSTRATEN, MC +3 more
openaire +3 more sources
Monoclonal Gammopathy of Undetermined Significance
British Journal of Haematology, 2005SummarySignificant advances have been made in our understanding of the natural history, pathogenesis, mechanisms of progression and prognosis of monoclonal gammopathy of undetermined significance (MGUS). Although the overall incidence of MGUS progression is 1 per year, it is now possible to more accurately predict the risk of progression based on a new
Robert A, Kyle, S Vincent, Rajkumar
openaire +3 more sources
The Monoclonal Gammopathies (Paraproteins)
1990Publisher Summary This chapter discusses the pathogenesis of monoclonal gammopathies, including their cause, animal models, and role of T and B lymphocytes, cytogenetic aspects, and molecular biology. It focusses on the recognition of monoclonal proteins in the clinical chemistry laboratory, and a practical classification of the monoclonal ...
R A, Kyle, J A, Lust
openaire +2 more sources
Monoclonal Gammopathy-Associated Neuropathy
Current Hematologic Malignancy ReportsPeripheral neuropathy (PN) is more commonly seen in individuals with monoclonal gammopathies, especially in patients with an IgM monoclonal gammopathy or Waldenström macroglobulinemia.There are multiple potential ways that the paraprotein may result in peripheral neuropathy.
Shayna, Sarosiek +2 more
openaire +2 more sources
Monoclonal Gammopathy in Lymphoma
Archives of Internal Medicine, 1975Serum protein electrophoresis was performed in 68% of 1,682 consecutive patients with lymphoma. Of 400 patients with chronic lymphocytic leukemia and lymphocytic lymphoma, 2.3% had an IgG peak, a frequency significantly higher than that found in normal individuals of comparable age. IgM peaks occurred in 4.5% of patients with lymphomas characterized by
openaire +2 more sources
La Revue du praticien, 2006
Monoclonal gammopathies can induce clinical or biological symptoms, independent of any associated hemopathy. Cryoglobulins types I and II are responsible for cutaneous lesions, peripheral neuropathy, and membranoproliferative glomerulopathy. Peripheral neuropathies associated with monoclonal gammopathy are chronic, distal, symmetrical and progressive ...
openaire +1 more source
Monoclonal gammopathies can induce clinical or biological symptoms, independent of any associated hemopathy. Cryoglobulins types I and II are responsible for cutaneous lesions, peripheral neuropathy, and membranoproliferative glomerulopathy. Peripheral neuropathies associated with monoclonal gammopathy are chronic, distal, symmetrical and progressive ...
openaire +1 more source
Neuropathy and monoclonal gammopathy
2013The association of neuropathy with monoclonal gammopathy has been known for several years, even if the clinical and pathogenetic relevance of this association is not completely defined. This is not a marginal problem since monoclonal gammopathy is present in 1-3% of the population above 50 years in whom it is often asymptomatic, and in at least 8% of ...
openaire +3 more sources
Monoclonal gammopathy and neuropathy
Current Opinion in Neurology, 1996There is a known coexistence between polyneuropathy and monoclonal gammopathy (immunoglobulin M, immunoglobulin G, immunoglobulin A). Antibodies to several glycoconjugates of the peripheral nervous system have been found in 50-65% of patients with immunoglobulin M monoclonal proteins, and distinct clinical syndromes have been recognized. However, if no
openaire +2 more sources
Monoclonal Gammopathy of Undetermined Significance
The American Journal of Medicine, 1978Monoclonal gammopathy of undetermined significance (MGUS) accounted for 56% of the 1026 patients with a monoclonal plasma cell disorder seen at the Mayo Clinic during 1992. Approximately 3% of persons older than 70 years and 1% of those older than 50 years had MGUS.
openaire +3 more sources